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Abstract Although psychiatric problems are less preva-
lent in old age within the general population, it is largely
unknown whether this extends to individuals with autism
spectrum disorders (ASD). We examined psychiatric
symptoms and disorders in young, middle-aged, and older
adults with and without ASD (Nmax = 344, age
19–79 years, IQ[ 80). Albeit comparable to other psy-
chiatric patients, levels of symptoms and psychological
distress were high over the adult lifespan; 79 % met criteria
for a psychiatric disorder at least once in their lives.
Depression and anxiety were most common. However,
older adults less often met criteria for any psychiatric
diagnosis and, specifically, social phobia than younger
adults. Hence, despite marked psychological distress, psy-
chiatric problems are also less prevalent in older aged
individuals with ASD.
Keywords Autism spectrum disorder  Psychiatric
comorbidity  Aging  Adults  Depression  Anxiety
Introduction
Psychopathology is a frequently occurring phenomenon. In
the general population, approximately 40 % meets criteria
for a psychiatric disorder at least once in their lives (Bijl
et al. 1998; Kessler et al. 2005). This rate is much higher in
individuals with an autism spectrum disorder (ASD), a
heterogeneous neurodevelopmental disorder characterized
by atypicalities in social communication and interaction
and repetitive stereotyped behavior (American Psychiatric
Association 2013). In this population, at least 69 % is
thought to suffer from co-occurring psychiatric disorders
and symptoms (Buck et al. 2014), even though rates are
lower in individuals with ASD and intellectual disability
(ID) (Howlin and Moss 2012; Matson and Cervantes
2014). The presence of co-occurring disorders is associated
with lower quality of life, greater demands for professional
help, poorer prognosis, greater interference with everyday
life, and worse outcome (Lainhart 1999; Matson and
Cervantes 2014; Seltzer et al. 2004; Vannucchi et al. 2014;
Wood and Gadow 2010). Furthermore, specifically the co-
occurring symptoms and disorders often constitute a target
for treatment, leading to an amelioration of problems. For
example, various psychotropic medications are frequently
prescribed to individuals with ASD to treat associated
symptoms (Aman et al. 2005; Buck et al. 2014; Esbensen
et al. 2009; Logan et al. 2015; Seltzer et al. 2004). As ASD
is considered a lifelong disorder (Piven et al. 1996; Seltzer
et al. 2004) and symptoms of psychopathology are likely to
wax and wane across the adult lifespan, knowledge
regarding associated psychopathology in older adulthood is
needed (Matson and Cervantes 2014; Perkins and Berkman
2012) to be able to provide adequate support for these
older individuals. This will be the focus of the current
study.
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In the general population, age is a relevant factor for
psychopathology. The prevalence of psychiatric disorders
and their nature is different in older adulthood than in
middle or young adulthood (Bijl et al. 1998; Kessler et al.
2005). While the general prevalence of psychiatric disor-
ders is lower, the prevalence of, for example, alcohol or
substance related disorders decreases sharply with
increasing age, whereas depression and anxiety are still
highly prevalent (Beekman et al. 1998; Wolitzky-Taylor
et al. 2010).
While traditionally many ASD studies mainly focused
on co-occurring symptoms and disorders in childhood (de
Bruin et al. 2007; Leyfer et al. 2006; Lundstro¨m et al.
2015; Mattila et al. 2010; Mukaddes et al. 2010; Simonoff
et al. 2008; Sinzig et al. 2009; van Steensel et al. 2013;
Verheij et al. 2015), recently a steadily increasing number
of studies have taken into account co-occurring symptoms
and disorders in adulthood (Buck et al. 2014; Cervantes
and Matson 2015; Croen et al. 2015; Ghaziuddin and Zafar
2008; Hofvander et al. 2009; Joshi et al. 2013; Lugnega˚rd
et al. 2011; Maddox and White 2015; Roy et al. 2015).
These findings seem to suggest that also in the ASD pop-
ulation age is an important factor. In childhood, attention
deficit hyperactivity disorder (ADHD), behavioral disorder,
and anxiety disorders are the most prevalent comorbid
disorders (de Bruin et al. 2007; Leyfer et al. 2006;
Simonoff et al. 2008; Sinzig et al. 2009), whereas in
adulthood, next to ADHD and anxiety disorders, mood
disorders are common (Croen et al. 2015; Ghaziuddin et al.
2002; Ghaziuddin and Zafar 2008; Hofvander et al. 2009;
Joshi et al. 2013; Roy et al. 2015; Sterling et al. 2008). In
various adult studies, older adults with ASD have been
included but only a few directly compared older adults with
younger individuals (Roy et al. 2015; Totsika et al. 2010).
In an intellectually challenged (ID) sample, psychiatric
disorders were less frequent in older adults with ASD and
ID compared to younger adults with ASD and ID (Totsika
et al. 2010). In contrast, in older adults with ASD without
ID, co-occurring psychiatric disorders were more common
than in younger adults (Roy et al. 2015). Unfortunately, the
‘‘older group’’ in this latest study was relatively young (age
range 40–62 years), the sample was small, and a statistical
comparison was lacking. A few studies focused on specific
psychiatric disorders such as anxiety (Davis et al. 2011)
and depression (Ghaziuddin et al. 2002). Whereas anxiety
seemed to reduce from childhood to young adulthood
(Davis et al. 2011), the risk for depression seemed to
increase with increasing age (Ghaziuddin et al. 2002). A
small study in older adults (53–83 years) with ASD
reported high levels of psychological and somatic
complaints and of psychological distress (van Heijst and
Geurts 2014). However, it has not been tested whether
these participants encountered a sufficient number of psy-
chiatric symptoms to meet diagnostic criteria, although
also associated symptoms in itself may cause clinically
relevant distress and impairment that may interfere with
quality of life and daily functioning. Thus, the nature and
prevalence of comorbid psychopathological symptoms and
disorders in older adults with ASD is largely unknown. In
the current study, we will, therefore, determine both the
occurrence of non-ASD symptomatology and co-occurring
psychiatric disorders across the adult lifespan in ASD by
comparing young, middle-aged, and older adults clinically
diagnosed with ASD without ID. We hypothesize psychi-
atric co-occurring symptoms and disorders to be substan-
tially higher in individuals with ASD than in controls over
the whole adult lifespan, but comparable to a normative
group of policlinic psychiatric patients (Joshi et al. 2013).
Given the mixed findings so far (Davis et al. 2011; Roy
et al. 2015; Totsika et al. 2010), we will examine whether
there will be differences in this co-occurrence of other
psychiatric symptoms and disorders between the three age
groups.
In addition to age, several other factors might affect the
prevalence of comorbid psychiatric disorders in individuals
with ASD, including ASD severity, gender, social eco-
nomic status (i.e., education and work), living situation,
and both intellectual and more general cognitive func-
tioning. We will explore their role with respect to the co-
occurring psychopathology in adults with ASD. For
example, in the general population vulnerability factors for
developing anxiety or depression are, among others, cog-
nitive decline, being female, having a lower social eco-
nomic status, or not having a partner (Beekman et al.
1998). In the ASD literature the focus has been mainly on
ASD severity, gender, and intellectual functioning but
whether these factors are indeed risk factors for comorbid
psychopathology in ASD is a topic of debate as results are
rather inconsistent (Cederlund et al. 2010; Garcı´a-Vil-
lamisar and Rojahn 2015; Gotham et al. 2015; Holtmann
et al. 2007; Jang and Matson 2015; Lai et al. 2011;
Lugnega˚rd et al. 2011; Moss et al. 2015; Simonoff et al.
2008, 2013; Sterling et al. 2008; Tureck et al. 2014; van
Steensel et al. 2012; Verheij et al. 2015). To restrict the
number of analyses we will solely explore whether all these
aforementioned factors are indeed risk factors correlated
with the most commonly co-occurring disorders in adults
with ASD, which we expect to be mood and anxiety dis-
orders (see for a similar approach in children Simonoff
et al. 2008, 2013).




Two-hundred-forty-seven adults with ASD between 19 and
79 years were recruited through several mental health
institutions across the Netherlands and by means of
advertisements on client organization websites. Individuals
with ASD traits, but without a prior clinical diagnosis of
ASD based on DSM-IV criteria (autism, Asperger’s syn-
drome, and Pervasive Developmental Disorder Not
Otherwise Specified) (American Psychiatric Association
2000), which was generally diagnosed by a multidisci-
plinary team involving a psychologist and/or psychiatrist,1
were not eligible to participate in the study.
Two-hundred-eight adults without ASD [comparison
(COM) group] were recruited by means of advertisements
on the university website and on social media, and within
the researchers’ social environment. Individuals with a
considerable amount of autistic traits, as measured with the
Autism-spectrum Quotient (AQ[ 32) (Baron-Cohen et al.
2001), or with close family members having ASD or
schizophrenia, were excluded.
For both groups, additional requirement upon partici-
pation was an absent history of neurological disorders
(e.g., epilepsy, stroke, cerebral contusion) or
schizophrenia. Four-hundred-five individuals met these
prerequisites (216 ASD, 189 COM). The study consisted
of two parts. Part I included the administration of a
questionnaire on psychological symptoms and distress
and medication usage, which was completed by 344
individuals (172 ASD, 172 COM) who constituted the
final sample of Part I. Part II included the administration
of a neuropsychiatric interview to examine psychiatric
disorders and an analysis of potential risk factors, and
was part of a larger study assessing age-related differ-
ences in cognition (Lever & Geurts 2015a). Eligible ASD
individuals were selected based on age to ascertain that
participants were evenly distributed across ages. IQ was
estimated with two subtests of the Dutch Wechsler Adult
Intelligence Scale third edition (WAIS-III) (Uterwijk
2000; Wechsler 1997) and the diagnoses of the ASD
participants were verified by administering the Autism
Diagnostic Observation Schedule module 4 (ADOS) (de
Bildt and de Jonge 2008; Lord et al. 2000). Four indi-
viduals (2 ASD, 2 COM) had an estimated IQ below 80
and were excluded from the sample of Part II. Of the
remaining 138 ASD participants, 37 scored below the
ADOS cut-off for ASD (\7), 49 below the autism
threshold (\10), and 52 above the autism threshold
(C10). As all these individuals had a clinical diagnosis
within the autism spectrum, diagnosed independently
from the present study by mental health professionals,
and the concordance between clinical diagnosis and
ADOS module 4 classification is not unequivocal in
intellectually able individuals (Bastiaansen et al. 2011a;
Pugliese et al. 2015; Ring et al. 2015), we included all
these ASD participants in the current study. Furthermore,
80 % scored above the threshold of 26 on the AQ
(Woodbury-Smith et al. 2005). All individuals had a Mini
Mental State Examination score above 26 (Folstein et al.
1975). Hence, with respect to Part II, the final sample for
the examination of co-occurring disorders was composed
of 138 ASD participants and 170 COM participants.
Based on a tertile split of this ASD group, the partici-
pants were assigned to a young (19–38 years), middle-aged
(39–54 years), and older (55–79 years) adult group
(Table 1). Please note that information about diagnostic
status, medical conditions, and medication usage was
obtained by means of self-report.
Measures
Psychiatric Co-occurring Symptoms
Symptom Checklist-90 Revised (SCL-90-R) The SCL-90-
R (Arrindell and Ettema 2005; Derogatis 1977) is a widely
used multidimensional self-report inventory consisting of
90 items to assess the presence of current psychopatho-
logical symptoms and psychological distress. Each item is
rated on a five-point Likert scale ranging from 0 ‘‘not at
all’’ to 4 ‘‘very much’’ and indicates how much distress was
caused during the last week comprising today. The original
SCL-90-R includes nine primary symptom dimensions and
three global indices that cover clinically relevant psychi-
atric and psychosomatic symptoms. The Dutch version
(Arrindell and Ettema 2005), however, measures eight
dimensions: anxiety, agoraphobia, depression, somatiza-
tion, cognitive-performance deficits, interpersonal sensi-
tivity and mistrust, hostility, and sleep difficulties. The
total score, psychoneuroticism, provides a general measure
of psychological distress. Higher scores indicate more
symptoms and distress. The psychometric properties of the
SCL-90-R, including internal consistency, test–retest reli-
ability, and convergent and divergent validity, are good to
very good (Arrindell and Ettema 2005).
1 Please note that the Dutch multidisciplinary guidelines (Trimbos
2013), based on the UK guidelines (National Institute for Health and
Clinical Excellence 2012), for diagnosis and treatment of ASD in
adults recommends that ASD is diagnosed by a psychiatrist or
psychologist experienced in diagnosing ASD who is embedded within
a multidisciplinary team, that review of developmental history is
necessary (but can be left out when unreliable, despite several
attempts to obtain it and when there are well-founded other clinical
indications of ASD being concerned), that multiple informants should
be asked about current functioning, and that assessment of co-existing
conditions should be included.
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N 172 52 72 48 172 60 47 65
Gender 4.27 1.75 4.45*
Male 116 33 45 38 97 37 23 37
Female 56 19 27 10 75 23 24 28
Educationa 11.98 15.14? 9.77?
Low 1 0 1 0 0 0 0 0
Middle 55 18 19 18 37 9 10 18
High 115 34 51 30 134 51 37 46
Diagnosis 6.71 – –
Autistic disorder 26 5 12 9 – – – –
Asperger 88 27 35 26 – – – –
PDD-NOS 53 16 24 13 – – – –
ASD 5 4 1 0 – – – –
ISCO 19.29** 49.93*** 7.70?
Class 1–3 62 11 37 14 80 19 36 25
Class 4–6 21 8 10 3 22 13 5 4
Class 7–9 11 2 4 5 4 4 0 0
Unemployed 74 30 20 24 57 23 1 33
Age (mean) 46.7 29.3 47.9 63.7 525.52*** 46.0 26.8 47.0 63.0 711.07*** 0.16
AQ (mean) 33.5 32.1 34.4 33.4 1.16 12.4 12.3 11.1 13.0 1.77 831.22***
IQ (mean) NA NA NA NA NA NA NA NA
MMSE (mean) NA NA NA NA NA NA NA NA
ADOS (mean) NA NA NA NA – – – –
Psychotropic medication 87 28 38 21 1.26 6 0 2 4 3.75 96.69***
Antidepressantsb 52 18 23 11 1.80 4 0 1 3 2.61? 49.14***
Anxiolytic/sedative/
hypnotics
19 6 8 5 0.10 1 0 0 1 1.61 17.20***
Antipsychotics 24 14 7 3 9.62** 0 0 0 0 – 25.80***
Stimulants 14 4 8 2 1.73 0 0 0 0 – 14.59***
Other psychotropic
medication
11 1 8 2 4.22 1 0 1 0 2.25 8.64**
Other non-psychotropic
medication
58 9 27 22 10.23** 55 6 15 34 27.04*** 0.12
Part II
N 138 46 47 45 170 60 46 64
Gender 3.83 1.47 5.09*
Male 96 31 29 36 97 37 23 37
Female 42 15 18 9 73 23 23 27
Educationa 10.77 13.49? 8.50?
Low 1 0 1 0 0 0 0 0
Middle 43 15 11 17 36 9 9 18
High 94 31 35 28 134 51 37 46
Diagnosis 6.82 – –
Autistic disorder 21 4 9 8 – – – –
Asperger 69 24 21 24 – – – –
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Psychiatric Co-occurring Disorders
Mini International Neuropsychiatric Interview Plus (MINI-
Plus) The MINI-Plus (Sheehan et al. 1998; van Vliet
et al. 2000) is a structured diagnostic interview that
explores several psychiatric disorders according to DSM-
IV criteria. First, two to four screenings questions are asked
for each disorder. Second, if any of these is answered
positively, additional questions further inquire about the
presence of a disorder. We inquired about mood, anxiety,
substance-related, eating, somatoform, and conduct disor-
ders. The MINI has good inter-rater and test–retest relia-
bility (Lecrubier et al. 1997; Sheehan et al. 1997). For the
current study, we adjusted wording of a small number of
questions, for example by splitting extended questions into
sub questions, to make them more comprehensible to
individuals with ASD and to be able of examining lifetime
adherence for all disorders. Although we did not change the
purport of the items, the validity of the MINI may have
been reduced due to these adjustments.
ADHD Rating Scale The ADHD rating scale (Kooij et al.
2005) is a 23-item self-report questionnaire to assess
ADHD symptoms based on DSM-IV criteria. Using the
adult scale, an individual rates the extent to which each
statement illustrates his or her behavior over the past
6 months on a four-point Likert scale, ranging from 0
‘‘rarely or never’’ to 3 ‘‘very often’’. Items rated with
‘‘often’’ or ‘‘very often’’ met diagnostic criteria for either

















Young Middle Older Fisher’s v2 or
F
v2
PDD-NOS 43 14 16 13 – – – –
ASD 5 4 1 0 – – – –
ISCO 14.98* 48.84*** 7.37?
Class 1–3 48 10 25 13 79 19 35 25
Class 4–6 16 7 6 3 22 13 5 4
Class 7–9 6 1 1 4 4 4 0 0
Unemployed 66 27 15 24 57 23 1 33
Age (mean) 46.5 28.8 47.2 63.9 481.64*** 45.9 26.8 47.2 62.9 703.46*** 0.11
AQ (mean) 33.5 31.7 35.2 33.4 2.06 12.2 12.3 11.0 13.0 1.83 723.60***
IQ (mean) 113.8 112.1 116.7 112.5 1.10 113.3 111.2 114.1 114.8 0.78 0.06
MMSE (mean) 29.0 28.9 29.1 29.1 0.57 29.1 29.3 29.1 29.0 1.41 0.71
ADOS (mean) 8.6 9.5 8.5 8.0 2.43? – – – – – –
Psychotropic medication 67 22 27 18 2.80 6 0 2 4 3.82 85.37***
Antidepressantsb 38 12 16 10 1.65 4 0 1 3 2.65 41.02***
Anxiolytic/sedative/
hypnotics
16 5 6 5 0.17 1 0 0 1 1.62 17.69***
Antipsychotics 18 11 4 3 6.46* 0 0 0 0 – 23.55***
Stimulants 9 4 4 1 2.11 0 0 0 0 – 11.42***
Other psychotropic
medication
9 1 7 1 6.73** 1 0 1 0 2.28 8.54**
Other non-psychotropic
medication
46 7 20 19 10.73** 53 6 14 33 26.08*** 0.16
ASD autism spectrum disorder, COM comparison group, PDD-NOS pervasive developmental disorder not otherwise specified, ISCO Interna-
tional Standard Classification of Occupations, AQ Autism-Spectrum Quotient, IQ estimated intelligence quotient, MMSE Mini Mental State
Examination, ADOS Autism Diagnostic Observation Schedule
a One missing in both groups
b Antidepressant medication refers to the use of non-selective monoamine reuptake inhibitors, selective serotonin reuptake inhibitors, and other
antidepressants
? p\ .1; * p B .05; ** p B .01; *** p B .001
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Following the DSM-IV (American Psychiatric Association
2000), we considered the presence of at least six out of nine
symptoms per subtype as indicative of an AD(H)D diag-
nosis. The validity of the ADHD rating scale is reasonable
(Kooij et al. 2008).
Risk Factors
ASD severity as measured with the AQ and ADOS, intel-
lectual functioning (IQ) as estimated with a short version of
the WAIS-III, general cognitive functioning as measured
with the MMSE, and information on education, work sit-
uation (coded according to the International Standard
Classification of Occupations [ISCO]), living situation,
gender, and age as indicated by self-report constituted the
factors that were considered as being potentially predictive
of psychopathology.
Procedure
Informed consent was obtained from all individual partic-
ipants included in the study, after which they filled out the
AQ and SCL-90, among other questionnaires (Part I).
Participants selected for Part II were tested in two sessions
during which (1) the ADOS, shortened WAIS-III, MMSE,
and MINI were administered, and (2) neuropsychological
and experimental testing took place (these are described
elsewhere) (e.g., Lever & Geurts 2015a). Participants who
were tested in at least one test session received compen-
sation for their travel expenses; most COM participants
also received additional compensation (max €20). The
study was approved by the institutional review board of the
University of Amsterdam and was in accordance with the




SCL-90-R variables were highly skewed and neither log,
square root, nor inverse transformation lead to normality.
However, as MANOVA is thought be robust against this
type of violation (Stevens 2012), we ran a MANOVA with
Diagnostic group (ASD, COM) and Age (young, middle-
aged, older) as between-subject factors and the total score
and SCL-90-R subscales as dependent variables. Raw
scores were then compared with normative data available
for the general population and a policlinic psychiatric
patient group (Arrindell and Ettema 2005). Analyses were
run with and without outliers (data points more than 3 SD
from group mean). When the pattern of results changed by
removing outliers, we report both analyses.
Psychiatric Co-occurring Disorders
Chi square tests were used to compare frequencies of
psychiatric disorders, as measured with the MINI-Plus and
ADHD list, between the ASD and COM group. We clus-
tered the inquired disorders into six major disorders: mood,
anxiety, substance-related, eating, somatoform, and atten-
tional and behavioral disorders and Bonferroni corrected
for multiple comparisons (i.e., significance level was set on
0.05/6 = 0.0083). Thereafter, Chi square tests were ran per
non-clustered disorder to compare the ASD and COM
group and Fisher’s exact test was used to compare fre-
quencies between young, middle-aged and older adults per
diagnostic group. No further correction was applied to
these analyses. Results per distinct disorder are presented
when group differences were significant after Bonferroni
correction. Otherwise, they are presented in the supple-
mentary material (Online Resource 1).
Risk Factors
Binomial logistic regressions and linear regressions were
run to assess the association between potential risk factors
and any mood or anxiety disorder and depression and
anxiety symptoms, respectively. Please note that we com-
puted these risk factor analyses on the sample of Part II
(due to the inclusion of IQ and ADOS) and that we
excluded the COM group from these analyses (as our focus
was on risk factors involved in the ASD group). All anal-
yses were conducted in SPSS 22.0 (IBM Corp. 2013).
Results
Psychiatric Co-occurring Symptoms
The SCL-90-R scores for Part I are presented in Table 2.
The omnibus MANOVA revealed a main effect of diag-
nostic group, K = 0.58, F(9, 330) = 26.42, p\ .001,
gp
2 = .42, but no main effect of age-group, K = 0.96, F(18,
660) = 0.82, p = .672, gp
2 = .02, nor an interaction effect,
K = 0.94, F(18, 660) = 1.15, p = .298, gp
2 = .03. The
ASD group had higher scores on all subscales and the total
score. This is in line with the findings when we compare
the scores of the ASD sample to the norms of a general
population sample as over a quarter of adults with ASD had
depression or anxiety scores that were considered very high
(C95th percentile). However, compared to a psychiatric
patient group, only a few individuals (\5 %) with ASD had
scores above the 95th percentile (Table 3), which suggest
that these high scores for individuals with ASD are com-
mon in individuals with psychiatric diagnoses.
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When running the MANOVA on the subgroup sample of
Part II, there was still a main effect of diagnostic group and
no main effect of age-group, but now the diagnostic group
by age-group interaction was significant, K = 0.88, F(18,
588) = 2.16, p = .004, gp
2 = .06, with generally a decrease
of reported symptoms with age in the ASD group and no
such a decrease in the COM group. After removing the
outliers, in addition to the already present effects, there was
also a main effect of age-group, K = 0.88, F(18,
542) = 1.95, p = .011, gp
2 = .06. The older age group
generally had lower scores than the younger groups, even
though this difference seemed more pronounced in the
ASD group.
Psychiatric Co-occurring Disorders
The frequencies of the investigated lifetime DSM-IV
diagnoses are presented in Table 4. In the ASD group,
79.0 % met one or more lifetime diagnosis for a psychiatric
disorder against 48.8 % of the COM group. Overall, older
adults with ASD less often met diagnostic criteria com-
pared to the younger age groups, whereas there were no
differences between age groups among adults without
ASD. In the ASD group, while 21 % did not meet criteria
for any psychiatric diagnoses and 20.3 % met criteria for
one psychopathology, over 57 % had more than one co-
occurring lifetime disorder. In the COM group, the large
majority did meet criteria for one or none lifetime DSM-IV
diagnosis. Nevertheless, a small percentage (15.9 %) of the
individuals without ASD had more than one co-occurring
psychopathology (Table 5).
As expected, in adults with ASD, mood disorders were
the most common group of psychiatric disorders (57.2 %)
and included major depression (53.6 %) and dysthymia
(18.1 %). Mood disorders were most prevalent in middle-
aged adults and least prevalent in the oldest age-group with
Table 2 SCL-90-R total and subscale scores for the young, middle-aged, and older adults with and without ASD
ASD COM ASD versus COMa
All ages Young Middle Older All ages Young Middle Older F gp
2
Psychoneuroticism 174.9 183.9 173.1 167.6 113.3 111.3 115.9 113.2 192.96*** .36
Agoraphobia 11.4 12.2 11.3 10.6 7.4 7.3 7.2 7.5 116.89*** .26
Anxiety 18.3 19.8 18.1 17.0 11.8 11.4 12.1 11.8 111.28*** .25
Depression 33.6 34.8 33.9 31.8 20.6 19.8 21.1 21.0 151.71*** .31
Somatization 20.5 21.6 20.8 18.9 15.3 15.4 15.5 15.1 62.81*** .16
Cognitive-performance deficits 21.1 21.7 21.1 20.5 12.5 12.7 12.7 12.2 208.91*** .38
Interpersonal sensitivity and mistrust 37.2 38.8 36.1 37.2 23.4 22.7 24.3 23.3 152.44*** .31
Hostility 9.9 10.8 9.5 9.3 7.0 7.1 7.2 6.8 83.57*** .20
Sleep difficulties 6.6 6.9 6.7 6.2 4.7 4.6 4.7 4.8 43.21*** .11
ASD autism spectrum disorder, COM comparison group
a We do not report the effects of age-group as the overall MANOVA revealed a nonsignificant effect, as denoted in the main text
Table 3 Number (%) of adults
with and without ASD scoring
above the 95th percentile
compared to a normative
general population and a
psychiatric patient sample
ASD COM
NOR PSY NOR PSY
Psychoneuroticism 69 (40.1 %) 3 (1.7 %) 5 (2.9 %) 0 (–)
Agoraphobia 79 (45.9 %) 1 (0.8 %) 2 (1.2 %) 0 (–)
Anxiety 44 (25.6 %) 1 (0.8 %) 2 (1.2 %) 0 (–)
Depression 70 (40.7 %) 1 (0.8 %) 5 (2.9 %) 0 (–)
Somatization 29 (16.9 %) 3 (1.7 %) 3 (1.7 %) 0 (–)
Cognitive-performance deficits 87 (50.6 %) 5 (2.9 %) 6 (3.5 %) 0 (–)
Interpersonal sensitivity and mistrust 67 (39.0 %) 8 (4.7 %) 9 (5.2 %) 0 (–)
Hostility 51 (29.7 %) 3 (1.7 %) 6 (3.5 %) 0 (–)
Sleep difficulties 42 (24.4 %) 4 (2.3 %) 10 (5.8 %) 0 (–)
ASD autism spectrum disorder, COM comparison group, NOR general population; PSY psychiatric patient
sample
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ASD. All mood disorders were more frequent in adults
with ASD than in adults without ASD. There were no
differences between age-groups in the COM group.
The second most common group of disorders in the
ASD group were the anxiety disorders (53.6 %) of which
obsessive–compulsive disorder (OCD; 21.7 %) and ago-
raphobia (21.0 %) most often occurred. The prevalence of
any anxiety disorder appeared slightly lower in older
adults, but it was not statistically significant. Whereas
social phobia was common in young and middle-aged
adults, it was not in older adults with ASD. All anxiety
disorders were more frequent in adults with ASD than in
adults without ASD. In the COM group, there were no
differences between age-groups.
As mood and anxiety disorders often co-occur (Beek-
man et al. 2000; Sartorius et al. 1996), we explored the
overlap between these two lifetime diagnoses (Fig. 1).
Over 65 % of the adults with ASD meeting criteria for any
lifetime mood or anxiety disorder, also met criteria for the
other co-occurring disorder.
Associations Between Potential Risk Factors
and Mood and Anxiety Symptoms
ASD severity by both self-report and ADOS was predictive
of the amount of depression and anxiety symptoms as mea-
sured with the SCL-90-R. None of the other factors was
significantly associated with these symptoms (Table 6).
Associations Between Potential Risk Factors
and any Mood and Anxiety Disorder
Female gender was a significant predictor of any mood
disorder. Lower age and more severe ASD as indicated by
self-report were associated with the presence of any anxi-
ety disorder. None of the other factors was associated with
any mood or anxiety disorder (Table 7).
Discussion
In the current study, we examined psychiatric symptoms
and disorders in young, middle-aged, and older adults with
ASD and focused on the two most frequently occurring
diagnoses (i.e., mood and anxiety) by testing several
potential risk factors covering different domains. As
expected, adults with ASD experienced more psychologi-
cal symptoms and distress compared to a typically devel-
oping comparison group. These elevated levels were not
only reported by older adults (for similar findings see van
Heijst and Geurts 2014), but were consistently high also in
young and middle-aged adults and, thus, across the adult
lifespan. Whereas at least a quarter of the adults with ASD
reported symptoms within the clinical range compared to a
population-based sample, only a few participants scored
within the clinical range when compared to a psychiatric
patient group (see also Joshi et al. 2013). These findings
indicate that, as expected, adults with ASD experience
many feelings of depression, anxiety, and psychological
distress, but this was not atypical when compared to other
psychiatric patients.
Consistent with the experience of many psychological
symptoms, is the high proportion of individuals meeting
criteria for a psychiatric diagnosis. Seventy-nine percent of
the adults with ASD have experienced any psychiatric
disorder once in their lives. As predicted, most common
disorders were mood (57 %) and anxiety disorders (54 %),
Table 5 Frequencies and percentages of the number of lifetime diagnoses in young, middle-aged, and older adults with and without ASD
ASD COM
All ages Young Middle Older All ages Young Middle Older
N % N % N % N % N % N % N % N %
No DSM-IV diagnoses 29 21.0 8 17.4 6 12.8 15 33.3 87 51.2 30 50.0 27 58.7 30 46.9
1 DSM-IV diagnosis 28 20.3 6 13.0 13 27.7 9 20.0 56 32.9 16 26.7 13 28.3 27 42.2
2 DSM-IV diagnoses 19 13.8 8 17.4 7 14.9 4 8.9 16 9.4 8 13.3 3 6.5 5 7.8
3 DSM-IV diagnoses 24 17.4 8 17.4 6 12.8 10 22.2 4 2.4 2 3.3 1 2.2 1 1.6
4 DSM-IV diagnoses 17 12.3 9 19.6 3 6.4 5 11.1 2 1.2 2 3.3 0 – 0 –
[4 DSM-IV diagnoses 21 15.2 7 15.2 12 25.5 2 4.4 5 2.9 2 3.3 2 4.3 1 1.6
ASD autism spectrum disorder, COM comparison group
Depression n=79 Anxiety n=74
5227 22
Fig. 1 Number of ASD participants showing overlap between mood
and anxiety disorders
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which often co-occur. ADHD frequently occurred as well
(30 %) and notable is the high percentage of females
meeting criteria for a premenstrual dysphoric disorder
(21 %). The estimated occurrences of psychiatric disorders
in a large group of adults with ASD is comparable to those
previously reported in other studies of adults without IDs
using the Structured Clinical Interview for DSM-IV axis I
Disorders (SCID-I) or a structured DSM-IV based clinical
interview (Hofvander et al. 2009; Lugnega˚rd et al. 2011;
Roy et al. 2015). The MINI is based on both the DSM-IV
and ICD-10 (Lecrubier et al. 1997) and the MINI and
SCID-I are well concordant with each other (Sheehan et al.
1997). Given the consistency with previous studies
involving a similar population, the current findings seem to
reflect the true lifetime psychiatric problems of adults with
ASD.
However, while others focused on young and middle-
aged adults, we also examined older adults and we found
that, also in late adulthood, psychiatric disorders were still
common. Nevertheless, lifetime diagnoses for any psychi-
atric disorder were less often present in older than in
younger adults with ASD, suggesting reduced psy-
chopathology in late adulthood, a pattern that has been
commonly observed in large typical aging studies (Bijl
et al. 1998; Kessler et al. 2005). Although a recent study
found the opposite (i.e., psychopathology was more com-
mon in older than in younger adults) in older adults with
ASD and without ID (Roy et al. 2015), this seems mainly
due to the inclusion of middle-aged adults in the ‘‘older’’
adult group (age range 40–62 years) in the study of Roy
and colleagues. Especially in mid adulthood, psychiatric
disorders such as depression seem more common than in
older or younger individuals (Bijl et al. 1998; Kessler et al.
2005). While our older adult group consisted of partici-
pants until 79 years of age, participants in the Roy study
were rather middle-aged, which would explain why high
rates were found and why our findings were apparently
discordant. We also observed that only one (2 %) older
adult met criteria for social phobia (i.e., social anxiety
disorder) against 21 % of young and middle-aged adults.
Of course, this could be due to a cohort effect. However,
there are several potential alternative explanations for this
latter finding. First, social phobia and social skills may
reciprocally influence each other: individuals with poor
social skills may be more likely to experience anxiety
related to social interactions, but, inversely, individuals
with social anxiety may less likely develop and practice
their social skills (Bellini 2004). In fact, adults with social
anxiety disorder report difficulties in social skills, similarly
to ASD individuals (Cath et al. 2008). Although social
symptoms tend to remain stable over time in ASD (Magiati
et al. 2014), social functioning seems to improve (Basti-
aansen et al. 2011b). Older adults would be more able to
adjust their behavior to social situations and cope with their
social difficulties, which could have a positive effect on
feeling more comfortable in social situations and a negative
effect on feelings of anxiety. Second, reduced social anx-
iety can be associated with a decrement in awareness or
concern about social situations, for example due to lower
empathic skills (Bellini 2004). However, neither empathic
concern (Lever and Geurts 2015b) nor theory of mind
(Lever and Geurts 2015a) declined in older adults with
ASD, suggesting that this explanation does not hold. Third,
older adults may have accepted their difficulties in social
Table 6 Risk factors associated with depression and anxiety symptoms (SCL-90-R) in adults with ASD
Depression Anxiety
B SE t 95 % CI B SE t 95 % CI
Age -0.05 0.07 -0.75 -0.18 to 0.08 -0.10 0.06 -1.62 -0.23 to 0.02
Gender 4.24 2.33 1.82 -0.37 to 8.84 3.85 2.25 1.71 -0.61 to 8.31
Education -1.98 2.23 -0.89 -6.40 to 2.44 -3.04 2.16 -1.41 -7.31 to 1.24
Living situation -0.53 1.06 -0.50 -2.63 to 1.58 -0.93 1.03 -0.91 -2.97 to 1.10
ISCO 0.05 0.73 0.07 -1.38 to 1.49 0.43 0.70 0.62 -0.96 to 1.83
IQ -0.06 0.07 -0.93 -0.19 to 0.07 0.01 0.06 0.18 -0.11 to 0.14
MMSE -0.57 1.04 -0.55 -2.63 to 1.49 -1.39 1.01 -1.38 -3.39 to 0.60
AQ 0.45 0.12 3.62*** 0.20 to 0.69 0.40 0.12 3.33*** 0.16 to 0.63
ADOS 0.89 0.34 2.66** 0.23 to 1.56 0.77 0.33 2.38* 0.13 to 1.42
Constant 36.94 28.45 1.30 -19.37 to 93.26 57.94 27.54 2.10* 3.44 to 112.45
R2 20.5 % 20.9 %
N 134 134
SCL-90-R Symptom Checklist 90 revised, ISCO International Standard Classification of Occupations, IQ estimated intelligence quotient, MMSE
Mini Mental State Examination, AQ Autism-spectrum Quotient, ADOS Autism Diagnostic Observation Schedule
* p B .05; ** p B .01; *** p B .001
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situations and, therefore, show less preoccupation and
anxiety. Finally, it could be that older adults experience
feelings of anxiety in social situations that are qualitatively
different than aspects captured by this type of assessment,
for example due to differential social settings and type of
interactions (Ciliberti et al. 2011). Future research is nee-
ded to test which of these potential explanations will hold.
In line with previous studies in adults with ASD (Gar-
cı´a-Villamisar and Rojahn 2015; Sterling et al. 2008),
individuals with more depression and anxiety symptoms
also demonstrated more severe self-reported and observed
ASD symptoms. When focusing on psychiatric disorders
rather than symptoms, higher self-reported ASD symp-
tomatology and lower age were associated with the pres-
ence of any lifetime anxiety disorder. This latest result
confirmed the already observed trend in the age-group
comparisons. Furthermore, female gender was associated
with any lifetime mood disorder, indicating that females
are more likely to receive a diagnosis of depression or
dysthymia than males. Although in line with observations
in the general population (Kessler et al. 2005), no such
gender differences have been detected in previous adult
ASD studies (Lai et al. 2011; Lugnega˚rd et al. 2011). The
use of self-report information (Lai et al. 2011) or the
inclusion of young adults (Lugnega˚rd et al. 2011) may
account for this discrepancy. As aforementioned we did not
find a relation between depressive symptoms and gender by
means of self-report either and when we (post hoc) selected
only young adults within our sample we also did not
observe a gender difference on mood disorder. Hence, our
findings do suggest that after young adulthood females with
ASD are more vulnerable for mood disorder than males
with ASD, just as reported in the general population. The
other variables (i.e., intellectual and general cognitive
functioning, social economic status [education and work],
and living situation), selected for their consistent relation-
ship with psychopathology in the general population, were
notably not associated with depression and anxiety symp-
toms and disorders in the ASD group.
Our study suffers from a few limitations that are of
importance to keep in mind when interpreting the findings.
First, we did neither include an epidemiological sample nor
did we adopt a longitudinal design. Therefore, our results
can be an overestimation of prevalence rates (Howlin and
Moss 2012) and cohort effects can bias our results. Within
the current design the directionality of effect cannot be
determined: For example, does more severe ASD symptoms
cause more psychiatric problems, or is more severe ASD
inherently related to psychopathology? Longitudinal
research may shed light on this issue. Second, the structured
nature of the MINI interview did not allow disentangling
whether specific symptoms were characteristic of the
investigated disorder or part of the ASD phenotype (e.g.,
OCD or social anxiety) (see Kerns and Kendall 2012; Wood
and Gadow 2010). A promising approach that might shed
light on the problem of defining diagnostic boundaries is
presented by the network perspective in which mental dis-
orders are conceptualized as networks of interacting symp-
toms rather than a latent construct (e.g., see Borsboom et al.
2011; Bringmann et al. 2013; Cramer et al. 2010). Third,
although prevalence rates of psychiatric disorders in adults
without ASD are largely comparable to those obtained in
epidemiological studies including a general population
sample (Bijl et al. 1998; Kessler et al. 2005), the frequency
of substance-related disorders was high. This is mainly due
to the prevalence of alcohol abuse (see Online Resource 1).
Table 7 Risk factors associated
with any mood and anxiety
disorder (MINI-Plus) in adults
with ASD
Any mood disorder Any anxiety disorder
B SE Odds Ratio 95 % CI B SE Odds Ratio 95 % CI
Age -0.00 0.01 1.00 0.97 to 1.02 -0.04 0.02 0.97* 0.94 to 1.00
Gender 1.46 0.49 4.29** 1.65 to 11.18 0.85 0.52 2.33 0.85 to 6.42
Education -0.14 0.44 0.87 0.37 to 2.04 -0.67 0.50 0.51 0.19 to 1.37
Living situation 0.18 0.21 1.20 0.80 to 1.80 0.04 0.23 1.05 0.67 to 1.64
ISCO -0.14 0.14 0.87 0.66 to 1.15 0.09 0.16 1.09 0.80 to 1.48
IQ -0.00 0.01 1.00 0.97 to 1.02 -0.01 0.01 0.99 0.96 to 1.02
MMSE -0.03 0.20 0.97 0.66 to 1.43 0.00 0.23 1.00 0.65 to 1.56
AQ 0.01 0.02 1.01 0.97 to 1.06 0.15 0.03 1.16*** 1.09 to 1.24
ADOS 0.02 0.07 1.02 0.90 to 1.16 0.04 0.07 1.04 0.90 to 1.20
Constant -0.56 5.42 0.57 -2.18 6.07 0.11
N 134 134
MINI-Plus Mini International Neuropsychiatric Interview, ISCO International Standard Classification of
Occupations, IQ estimated intelligence quotient, MMSE Mini Mental State Examination, AQ Autism-
spectrum Quotient, ADOS Autism Diagnostic Observation Schedule
* p B .05; ** p B .01; *** p B .001
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Fourth, diagnostic information was obtained by means of
self-report, even though we administered the ADOS to part
of the ASD sample to substantiate ASD diagnoses. Yet,
given the finding that group differences on a continuous
measure of psychopathology were also present in this sub-
sample, it is unlikely that our sampling method affected the
main conclusions. Fifth, our findings apply to adults with
ASD without ID and cannot be generalized to the entire
ASD population. Finally, although we investigated many
psychiatric disorders, we did not examine all. For example,
schizophrenia, bipolar disorder, and personality disorders
were not taken into consideration. Furthermore, we did not
focus on medical comorbidities, even though we did collect
information regarding the use of non-psychotropic medica-
tion. While the percentages of prescribed psychotropic drugs
are in line with the high number of observed psychiatric
diagnoses, the percentages of non-psychotropic medication
use in the ASD and COM group were similar. This might
suggest that there are no differences between groups with
regard to medical conditions, but this would be a premature
conclusion. Those with ASD might report less somatic
complaints to their general practitioner due to reduced sen-
sitivity to bodily signals or they might be more reluctant to
access the healthcare system due to, for example, commu-
nication and social difficulties or anxiety for medical
examination as a result of sensory sensitivities. Earlier
studies focusing on medical conditions in ASD reported
elevated rates compared to controls on many disorders,
including epilepsy, gastrointestinal and sleep disorders,
diabetes, and dyslipidemia (Croen et al. 2015; Kohane et al.
2012; Tyler et al. 2011). Hence, in future research it would
be worthwhile not to merely focus on psychiatric comor-
bidities but also on somatic comorbidities.
To conclude, in this large ASD adult cohort study
including older adults, we showed that psychopathology,
and specifically social phobia, less frequently occurred in
late adulthood. As these findings represent just an initial
step into the understanding of psychopathology across the
entire adult lifespan, further research into the nature of
psychiatric co-occurring symptoms and disorders and
intricate risk factors in old age is needed. Given that psy-
chiatric problems are, however, still common and psy-
chological distress is substantial, we need adequate
interventions and support to reduce the personal burden of
adults with ASD.
Acknowledgments We would like to thank all participants for their
time and effort, research assistants Nynke Dicke and Barbara van
Heijst for their overall help with conducting the study, and students
for their help with data collection.
Author Contributions AGL participated in the design and the
execution and coordination of the study, performed measurements
and the statistical analysis and interpretation of the data, and wrote the
manuscript; HMG supervised the study, participated in the design, the
set-up of the statistical plan and interpretation of the data, and helped
to draft the manuscript. Both authors read and approved the final
manuscript.
Funding This study was funded by Innovational Research Incen-
tives Scheme Vidi (NWO-MagW) awarded to Hilde M. Geurts (Grant
Number 452-10-003).
Compliance with Ethical Standards
Conflict of interest The authors declare that they have no conflict
of interest.
Ethical Approval All procedures performed in studies involving
human participants were in accordance with the ethical standards of
the institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards.
Informed Consent Informed consent was obtained from all indi-
vidual participants included in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Aman, M. G., Lam, K. S., & Van Bourgondien, M. E. (2005).
Medication patterns in patients with autism: Temporal, regional,
and demographic influences. Journal of Child & Adolescent
Psychopharmacology, 15(1), 116–126.
American Psychiatric Association. (2000). Diagnostic and statistical
manual of mental disorders (4th ed.). Washington, DC: Author.
American Psychiatric Association. (2013). The diagnostic and
statistical manual of mental disorders (5th ed.). Washington,
DC: Author.
Arrindell, W. A., & Ettema, J. H. M. (2005). SCL-90 Handleiding bij
een multidimensionale psychopathologie-indicator [SCL-90:
Manual for a multidimensional indicator of psychopathology].
Amsterdam: Pearson.
Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley,
E. (2001). The autism-spectrum quotient (AQ): Evidence from
asperger syndrome/high-functioning autism, males and females,
scientists and mathematicians. Journal of Autism and Develop-
mental Disorders, 31(1), 5–17.
Bastiaansen, J. A., Meffert, H., Hein, S., Huizinga, P., Ketelaars, C.,
Pijnenborg, M., et al. (2011a). Diagnosing autism spectrum
disorders in adults: The use of autism diagnostic observation
schedule (ADOS) module 4. Journal of Autism and Develop-
mental Disorders, 41(9), 1256–1266.
Bastiaansen, J. A., Thioux, M., Nanetti, L., van der Gaag, C.,
Ketelaars, C., Minderaa, R., & Keysers, C. (2011b). Age-related
increase in inferior frontal gyrus activity and social functioning
in autism spectrum disorder. Biological Psychiatry, 69(9),
832–838.
Beekman, A. T., Bremmer, M. A., Deeg, D. J., Van Balkom, A., Smit,
J. H., De Beurs, E., et al. (1998). Anxiety disorders in later life:
J Autism Dev Disord (2016) 46:1916–1930 1927
123
A report from the longitudinal aging study amsterdam. Interna-
tional Journal of Geriatric Psychiatry, 13(10), 717–726.
Beekman, A. T., de Beurs, E., van Balkom, A. J., Deeg, D. J., van
Dyck, R., & van Tilburg, W. (2000). Anxiety and depression in
later life: Co-occurrence and communality of risk factors.
American Journal of Psychiatry, 157(1), 89–95.
Bellini, S. (2004). Social skill deficits and anxiety in high-functioning
adolescents with autism spectrum disorders. Focus on Autism
and Other Developmental Disabilities, 19(2), 78–86.
Bijl, R., Ravelli, A., & Van Zessen, G. (1998). Prevalence of
psychiatric disorder in the general population: Results of the
Netherlands mental health survey and incidence study (NEM-
ESIS). Social Psychiatry and Psychiatric Epidemiology, 33(12),
587–595.
Borsboom, D., Cramer, A. O., Schmittmann, V. D., Epskamp, S., &
Waldorp, L. J. (2011). The small world of psychopathology.
PLoS One, 6(11), e27407.
Bringmann, L. F., Vissers, N., Wichers, M., Geschwind, N., Kuppens,
P., Peeters, F., et al. (2013). A network approach to psy-
chopathology: New insights into clinical longitudinal data. PLoS
One, 8(4), e60188.
Buck, T. R., Viskochil, J., Farley, M., Coon, H., McMahon, W. M.,
Morgan, J., & Bilder, D. A. (2014). Psychiatric comorbidity and
medication use in adults with autism spectrum disorder. Journal
of Autism and Developmental Disorders, 44(12), 3063–3071.
Cath, D. C., Ran, N., Smit, J. H., van Balkom, A. J., & Comijs, H. C.
(2008). Symptom overlap between autism spectrum disorder,
generalized social anxiety disorder and obsessive-compulsive
disorder in adults: A preliminary case-controlled study. Psy-
chopathology, 41(2), 101–110.
Cederlund, M., Hagberg, B., & Gillberg, C. (2010). Asperger
syndrome in adolescent and young adult males. Interview, self-
and parent assessment of social, emotional, and cognitive
problems. Research in Developmental Disabilities, 31(2),
287–298.
Cervantes, P. E., & Matson, J. L. (2015). Comorbid symptomology in
adults with autism spectrum disorder and intellectual disability.
Journal of Autism and Developmental Disorders, 45(12),
3961–3970.
Ciliberti, C., Gould, C., Smith, M., Chorney, D., & Edelstein, B.
(2011). A preliminary investigation of developmentally sensitive
items for the assessment of social anxiety in late life. Journal of
Anxiety Disorders, 25(5), 686–689.
Cramer, A. O., Waldorp, L. J., van der Maas, Han L. J., & Borsboom,
D. (2010). Comorbidity: A network perspective. Behavioral and
Brain Sciences, 33(2–3), 137–150.
Croen, L. A., Zerbo, O., Qian, Y., Massolo, M. L., Rich, S., Sidney,
S., & Kripke, C. (2015). The health status of adults on the autism
spectrum. Autism: The International Journal of Research and
Practice, 19(7), 814–823.
Davis, T. E., Moree, B. N., Dempsey, T., Reuther, E. T., Fodstad, J.
C., Hess, J. A., et al. (2011). The relationship between autism
spectrum disorders and anxiety: The moderating effect of
communication. Research in Autism Spectrum Disorders, 5(1),
324–329.
de Bildt, A., & de Jonge, M. V. (2008). Autisme diagnostisch
observatie schema. Amsterdam: Hogrefe.
de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F., & Verheij,
F. (2007). High rates of psychiatric co-morbidity in PDD-NOS.
Journal of Autism and Developmental Disorders, 37(5),
877–886.
Derogatis, L. R. (1977). Administration, scoring, and procedures
manual for the SCL-90-R. Baltimore, MD: Clinical Psychomet-
rics Research.
Esbensen, A. J., Seltzer, M. M., Lam, K. S., & Bodfish, J. W. (2009).
Age-related differences in restricted repetitive behaviors in
autism spectrum disorders. Journal of Autism and Developmen-
tal Disorders, 39(1), 57–66.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). ‘‘Mini-
mental state’’: A practical method for grading the cognitive state
of patients for the clinician. Journal of Psychiatric Research,
12(3), 189–198.
Garcı´a-Villamisar, D., & Rojahn, J. (2015). Comorbid psychopathol-
ogy and stress mediate the relationship between autistic traits
and repetitive behaviours in adults with autism. Journal of
Intellectual Disability Research, 59(2), 116–124.
Ghaziuddin, M., Ghaziuddin, N., & Greden, J. (2002). Depression in
persons with autism: Implications for research and clinical care.
Journal of Autism and Developmental Disorders, 32(4),
299–306.
Ghaziuddin, M., & Zafar, S. (2008). Psychiatric comorbidity of adults
with autism spectrum disorders. Clinical Neuropsychiatry, 5(1),
9–12.
Gotham, K., Unruh, K., & Lord, C. (2015). Depression and its
measurement in verbal adolescents and adults with autism
spectrum disorder. Autism, 19(4), 491–504.
Hofvander, B., Delorme, R., Chaste, P., Nyde´n, A., Wentz, E.,
Sta˚hlberg, O., et al. (2009). Psychiatric and psychosocial
problems in adults with normal-intelligence autism spectrum
disorders. BMC Psychiatry, 9(1), 35–44.
Holtmann, M., Bo¨lte, S., & Poustka, F. (2007). Autism spectrum
disorders: Sex differences in autistic behaviour domains and
coexisting psychopathology. Developmental Medicine and Child
Neurology, 49(5), 361–366.
Howlin, P., & Moss, P. (2012). In review-adults with autism spectrum
disorders. Canadian Journal of Psychiatry, 57(5), 275–283.
IBM Corp. (2013). IBM SPSS statistics for windows (Version 22.0).
Armonk, NY: IBM Corp.
Jang, J., & Matson, J. L. (2015). Autism severity as a predictor of
comorbid conditions. Journal of Developmental and Physical
Disabilities, 27(3), 405–415.
Joshi, G., Wozniak, J., Petty, C., Martelon, M. K., Fried, R., Bolfek,
A., et al. (2013). Psychiatric comorbidity and functioning in a
clinically referred population of adults with autism spectrum
disorders: A comparative study. Journal of Autism and Devel-
opmental Disorders, 43(6), 1314–1325.
Kerns, C. M., & Kendall, P. C. (2012). The presentation and
classification of anxiety in autism spectrum disorder. Clinical
Psychology-Science and Practice, 19(4), 323–347.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R.,
& Walters, E. E. (2005). Lifetime prevalence and age-of-onset
distributions of DSM-IV disorders in the national comorbidity
survey replication. Archives of General Psychiatry, 62(6),
593–602.
Kohane, I. S., McMurry, A., Weber, G., MacFadden, D., Rappaport,
L., Kunkel, L., et al. (2012). The co-morbidity burden of children
and young adults with autism spectrum disorders. PLoS One,
7(4), e33224.
Kooij, J. J. S., Buitelaar, J. K., van den Oord, E. J., Furer, J. W.,
Rijnders, C. A. T., & Hodiamont, P. P. G. (2005). Internal and
external validity of attention-deficit hyperactivity disorder in a
population-based sample of adults. Psychological Medicine,
35(06), 817–827.
Kooij, J. J. S., Marije Boonstra, A., Swinkels, S. H., Bekker, E. M., de
Noord, I., & Buitelaar, J. K. (2008). Reliability, validity, and
utility of instruments for self-report and informant report
concerning symptoms of ADHD in adult patients. Journal of
Attention Disorders, 11(4), 445–458.
Lai, M., Lombardo, M. V., Pasco, G., Ruigrok, A., Wheelwright, S. J.,
Sadek, S. A., et al. (2011). A behavioral comparison of male and
female adults with high functioning autism spectrum conditions.
PLoS One, 6(6), e20835.
1928 J Autism Dev Disord (2016) 46:1916–1930
123
Lainhart, J. E. (1999). Psychiatric problems in individuals with
autism, their parents and siblings. International Review of
Psychiatry, 11(4), 278–298.
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I.,
Harnett Sheehan, K., et al. (1997). The mini international
neuropsychiatric interview (MINI). A short diagnostic structured
interview: Reliability and validity according to the CIDI.
European Psychiatry, 12(5), 224–231.
Lever, A. G., & Geurts, H. M. (2015a). Age-related differences in
cognition across the adult lifespan in autism spectrum disorder.
Autism Research. doi:10.1002/aur.1545.
Lever, A. G., & Geurts, H. M. (2015b). Lifelong lasting? Self- and
other-reported ASD symptoms across adulthood. Unpublished
manuscript.
Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E.,
Morgan, J., et al. (2006). Comorbid psychiatric disorders in
children with autism: Interview development and rates of
disorders. Journal of Autism and Developmental Disorders,
36(7), 849–861.
Logan, S. L., Carpenter, L., Leslie, R. S., Garrett-Mayer, E., Hunt,
K. J., Charles, J., & Nicholas, J. S. (2015). Aberrant behaviors
and co-occurring conditions as predictors of psychotropic
polypharmacy among children with autism spectrum disorders.
Journal of Child and Adolescent Psychopharmacology, 25(4),
323–336.
Lord, C., Risi, S., Lambrecht, L., Cook, E. H, Jr, Leventhal, B. L.,
DiLavore, P. C., et al. (2000). The autism diagnostic observation
Schedule—Generic: A standard measure of social and commu-
nication deficits associated with the spectrum of autism. Journal
of Autism and Developmental Disorders, 30(3), 205–223.
Lugnega˚rd, T., Hallerba¨ck, M. U., & Gillberg, C. (2011). Psychiatric
comorbidity in young adults with a clinical diagnosis of asperger
syndrome. Research in Developmental Disabilities, 32(5),
1910–1917.
Lundstro¨m, S., Reichenberg, A., Melke, J., Ra˚stam, M., Kerekes, N.,
Lichtenstein, P., et al. (2015). Autism spectrum disorders and
coexisting disorders in a nationwide swedish twin study. Journal
of Child Psychology and Psychiatry, 56(6), 702–710.
Maddox, B. B., & White, S. W. (2015). Comorbid social anxiety
disorder in adults with autism spectrum disorder. Journal of
Autism and Developmental Disorders, 45(12), 3949–3960.
Magiati, I., Tay, X. W., & Howlin, P. (2014). Cognitive, language,
social and behavioural outcomes in adults with autism spectrum
disorders: A systematic review of longitudinal follow-up studies
in adulthood. Clinical Psychology Review, 34(1), 73–86.
Matson, J. L., & Cervantes, P. E. (2014). Commonly studied
comorbid psychopathologies among persons with autism spec-
trum disorder. Research in Developmental Disabilities, 35(5),
952–962.
Mattila, M., Hurtig, T., Haapsamo, H., Jussila, K., Kuusikko-Gauffin,
S., Kielinen, M., et al. (2010). Comorbid psychiatric disorders
associated with asperger syndrome/high-functioning autism: A
community-and clinic-based study. Journal of Autism and
Developmental Disorders, 40(9), 1080–1093.
Moss, P., Howlin, P., Savage, S., Bolton, P., & Rutter, M. (2015). Self
and informant reports of mental health difficulties among adults
with autism findings from a long-term follow-up study. Autism,
19(7), 832–841.
Mukaddes, N. M., Hergu¨ner, S., & Tanidir, C. (2010). Psychiatric
disorders in individuals with high-functioning autism and
asperger’s disorder: Similarities and differences. The World
Journal of Biological Psychiatry, 11(8), 964–971.
National Institute for Health and Clinical Excellence. (2012). Autism:
Recognition, referral, diagnosis and management of adults on
the autism spectrum. NICE clinical guideline 142. http://
guidance.nice.org.uk/CG142 (NICE guideline).
Perkins, E. A., & Berkman, K. A. (2012). Into the unknown: Aging
with autism spectrum disorders. American Journal on Intellec-
tual and Developmental Disabilities, 117(6), 478–496.
Piven, J., Harper, J., Palmer, P., & Arndt, S. (1996). Course of
behavioral change in autism: A retrospective study of high-IQ
adolescents and adults. Journal of the American Academy of
Child and Adolescent Psychiatry, 35(4), 523–529.
Pugliese, C. E., Kenworthy, L., Bal, V. H., Wallace, G. L., Yerys, B.
E., Maddox, B. B., et al. (2015). Replication and comparison of
the newly proposed ADOS-2, module 4 algorithm in ASD
without ID: A multi-site study. Journal of Autism and Devel-
opmental Disorders, 45(12), 3919–3931.
Ring, M., Gaigg, S. B., & Bowler, D. M. (2015). Relational memory
processes in adults with autism spectrum disorder. Autism
Research. doi:10.1002/aur.1493.
Roy, M., Prox-Vagedes, V., Ohlmeier, M. D., & Dillo, W. (2015).
Beyond childhood: Psychiatric comorbidities and social back-
ground of adults with asperger syndrome. Psychiatria Danubina,
27(1), 50–59.
Sartorius, N., U¨stu¨n, T. B., Lecrubier, Y., & Wittchen, H. (1996).
Depression comorbid with anxiety: Results from the WHO study
on ‘‘psychological disorders in primary health care’’. The British
Journal of Psychiatry, 168(30), 38–43.
Seltzer, M. M., Shattuck, P., Abbeduto, L., & Greenberg, J. S. (2004).
Trajectory of development in adolescents and adults with autism.
Mental Retardation and Developmental Disabilities Research
Reviews, 10(4), 234–247.
Sheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller,
E., Keskiner, A., et al. (1997). The validity of the mini
international neuropsychiatric interview (MINI) according to
the SCID-P and its reliability. European Psychiatry, 12(5),
232–241.
Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P., Janavs, J.,
Weiller, E., et al. (1998). The mini-international neuropsychi-
atric interview (M.I.N.I.): The development and validation of a
structured diagnostic psychiatric interview for DSM-IV and
ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
Simonoff, E., Jones, C. R., Baird, G., Pickles, A., Happe´, F. G. E., &
Charman, T. (2013). The persistence and stability of psychiatric
problems in adolescents with autism spectrum disorders. Journal
of Child Psychology and Psychiatry, 54(2), 186–194.
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., &
Baird, G. (2008). Psychiatric disorders in children with autism
spectrum disorders: Prevalence, comorbidity, and associated
factors in a population-derived sample. Journal of the American
Academy of Child and Adolescent Psychiatry, 47(8), 921–929.
Sinzig, J., Walter, D., & Doepfner, M. (2009). Attention deficit/
hyperactivity disorder in children and adolescents with autism
spectrum disorder symptom or syndrome? Journal of Attention
Disorders, 13(2), 117–126. doi:10.1177/1087054708326261.
Sterling, L., Dawson, G., Estes, A., & Greenson, J. (2008).
Characteristics associated with presence of depressive symptoms
in adults with autism spectrum disorder. Journal of Autism and
Developmental Disorders, 38(6), 1011–1018.
Stevens, J. P. (2012). Applied multivariate statistics for the social
sciences. New York, NY: Routledge.
Totsika, V., Felce, D., Kerr, M., & Hastings, R. P. (2010). Behavior
problems, psychiatric symptoms, and quality of life for older
adults with intellectual disability with and without autism.
Journal of Autism and Developmental Disorders, 40(10),
1171–1178.
Trimbos. (2013). Multidisciplinaire richtlijn diagnostiek en behan-
deling van autismespectrumstoornissen bij volwassenen.
Utrecht: De Tijdstroom.
Tureck, K., Matson, J. L., Cervantes, P., & Konst, M. J. (2014). An
examination of the relationship between autism spectrum
J Autism Dev Disord (2016) 46:1916–1930 1929
123
disorder, intellectual functioning, and comorbid symptoms in
children. Research in Developmental Disabilities, 35(7),
1766–1772.
Tyler, C. V., Schramm, S. C., Karafa, M., Tang, A. S., & Jain, A. K.
(2011). Chronic disease risks in young adults with autism
spectrum disorder: Forewarned is forearmed. American Journal
on Intellectual and Developmental Disabilities, 116(5), 371–380.
Uterwijk, J. (2000). WAIS-III nederlandstalige bewerking. Technische
handleiding. Lisse: Swets & Zeitlinger.
van Heijst, B. F. C., & Geurts, H. M. (2014). Quality of life in autism
across the lifespan: A meta-analysis. Autism, 19(2), 158–167.
van Steensel, F. J., Bo¨gels, S. M., & de Bruin, E. I. (2013). Psychiatric
comorbidity in children with autism spectrum disorders: A
comparison with children with ADHD. Journal of Child and
Family Studies, 22(3), 368–376.
van Steensel, F. J., Bo¨gels, S. M., & Dirksen, C. D. (2012). Anxiety
and quality of life: Clinically anxious children with and without
autism spectrum disorders compared. Journal of Clinical Child
& Adolescent Psychology, 41(6), 731–738.
van Vliet, I. M., Leroy, H., & van Megen, H. J. G. M. (2000). De
MINI internationaal neuropsychiatrisch interview, nederlandse
versie 5.0.0. Leiden: Leiden University Medical Center, Depart-
ment of Psychiatry.
Vannucchi, G., Masi, G., Toni, C., Dell’Osso, L., Marazziti, D., &
Perugi, G. (2014). Clinical features, developmental course, and
psychiatric comorbidity of adult autism spectrum disorders. CNS
Spectrums, 19(02), 157–164.
Verheij, C., Louwerse, A., van der Ende, J., Eussen, M., Van Gool,
A., Verheij, F., et al. (2015). The stability of comorbid
psychiatric disorders: A 7 year follow up of children with
pervasive developmental disorder-not otherwise specified. Jour-
nal of Autism and Developmental Disorders, 45(12), 3939–3948.
Wechsler, D. (1997). Wechsler adult intelligence scale (WAIS-III).
San Antonio, TX: Psychological Corporation.
Wolitzky-Taylor, K. B., Castriotta, N., Lenze, E. J., Stanley, M. A., &
Craske, M. G. (2010). Anxiety disorders in older adults: A
comprehensive review. Depression and Anxiety, 27(2), 190–211.
Wood, J. J., & Gadow, K. D. (2010). Exploring the nature and
function of anxiety in youth with autism spectrum disorders.
Clinical Psychology: Science and Practice, 17(4), 281–292.
Woodbury-Smith, M., Robinson, J., Wheelwright, S., & Baron-
Cohen, S. (2005). Screening adults for asperger syndrome using
the AQ: A preliminary study of its diagnostic validity in clinical
practice. Journal of Autism and Developmental Disorders, 35(3),
331–335.
1930 J Autism Dev Disord (2016) 46:1916–1930
123
